Latest Census Bureau data highlights health care struggles despite rising Maine incomes
Published . Updated .
This report is about pharma and health.
Directly affected
- No company is named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “health care” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “health care” (pharma and health) in this story.
- LLY Eli Lilly and+19.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “health care” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.9% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “health care” (pharma and health) in this story.
- PFE Pfizer+8.5% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “health care” (pharma and health) in this story.
- MRK Merck+1.0% 17d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “health care” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XLV | -2.61% | -2.65% | base | +0.53% | after close | after close | after close |
| XBI | -5.24% | -1.88% | base | -1.08% | after close | after close | after close |
| LLY | -7.22% | -6.69% | base | +3.03% | after close | after close | after close |
| JNJ | -4.11% | -2.34% | base | -0.44% | after close | after close | after close |
| PFE | +0.20% | -0.53% | base | +1.77% | after close | after close | after close |
| MRK | -0.71% | -3.06% | base | +2.20% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Latest Census Bureau data highlights health care struggles despite rising Maine incomes https://www.mecep.org/
Source: https://www.mecep.org/
Select Sector Spdr Tr (XLV) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Johnson & Johnson (JNJ) | that day | -0.44% | final price |
| Johnson & Johnson (JNJ) | three days earlier | -2.34% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -4.11% | final price |
| Eli Lilly (LLY) | that day | +3.03% | final price |
| Eli Lilly (LLY) | three days earlier | -6.69% | final price |
| Eli Lilly (LLY) | five days earlier | -7.22% | final price |
| Merck (MRK) | that day | +2.20% | final price |
| Merck (MRK) | three days earlier | -3.06% | final price |
| Merck (MRK) | five days earlier | -0.71% | final price |
| Pfizer (PFE) | that day | +1.77% | final price |
| Pfizer (PFE) | three days earlier | -0.53% | final price |
| Pfizer (PFE) | five days earlier | +0.20% | final price |
| Spdr Series Trust (XBI) | that day | -1.08% | final price |
| Spdr Series Trust (XBI) | three days earlier | -1.88% | final price |
| Spdr Series Trust (XBI) | five days earlier | -5.24% | final price |
| Select Sector Spdr Tr (XLV) | that day | +0.53% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -2.65% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -2.61% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 52 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 70 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 36 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 72 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Select Sector Spdr Tr (XLV)
Companies tied to this story
- XLV Select Sector Spdr Tr
In “Latest Census Bureau data highlights health care struggles despite rising Maine incomes,” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “health care” (pharma and health) in this story
- XBI Spdr Series Trust
In “Latest Census Bureau data highlights health care struggles despite rising Maine incomes,” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “health care” (pharma and health) in this story
- LLY Eli Lilly
In “Latest Census Bureau data highlights health care struggles despite rising Maine incomes,” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “health care” (pharma and health) in this story
- JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 30 Oct 2026 story “Latest Census Bureau data highlights health care struggles despite rising Maine incomes.” Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “health care” (pharma and health) in this story
- PFE Pfizer
For “Latest Census Bureau data highlights health care struggles despite rising Maine incomes,” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “health care” (pharma and health) in this story
- MRK Merck
In “Latest Census Bureau data highlights health care struggles despite rising Maine incomes,” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “health care” (pharma and health) in this story
Select Sector Spdr Tr (XLV)
Select Sector Spdr Tr (XLV) is the company in “Latest Census Bureau data highlights health care struggles despite rising Maine incomes,” the 30 Oct 2026 this story story.
The link for Select Sector Spdr Tr (XLV) is this: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “health care” (pharma and health) in this story
A second company, Spdr Series Trust (XBI), is listed for a different reason: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “health care” (pharma and health) in this story
Price levels for Select Sector Spdr Tr (XLV)
LLY traded between 1131.55 and 1406.90 across 20 sessions. The latest close on file is 1372.99.
How strong the case is around Select Sector Spdr Tr (XLV)
46 out of 100
“Latest Census Bureau data highlights health care struggles despite rising Maine incomes” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.